Circulating Nucleic Acids

LiquidBiopsy_lncRNAExosomes_700x233

Tackle the challenges of circulating tumor DNA (ctDNA) research and non-invasive prenatal testing (NIPT)

At the frontier of liquid biopsy, NIPT (noninvasive prenatal testing) is increasingly being used to screen and test chromosomal abnormalities by analyzing cell-free fetal DNA circulating in maternal blood. Similarly, since disease-specific mutations or alterations of the circulating cell-free DNA (cfDNA) are frequently found in serum samples of cancer patients, research into cctDNA testing as… Read article →


TEP_platelets_700x233

Now trending: the use of liquid biopsy to monitor tumor dynamics

Trends on social media and internet search engines can be used as tools to provide up-to-the-minute public opinion on just about any topic, from movies to presidential candidates. Liquid biopsy may be able to provide the same type of real-time (although not instantaneous) information about therapeutic efficacy as well as emerging drug resistance. Solid tumor… Read article →


S_4652_GG_visual

Webinar download: Automate and standardize processes for cell-free DNA in liquid biopsy

Circulating, cell-free DNA (cfDNA), which can originate from malignant tumors, the developing fetus or inflammatory tissues, is present among the cell-free nucleic acids in plasma, serum and other body fluids. Recently, cfDNA has become a powerful tool in non-invasive prenatal testing (NIPT), as well as in liquid biopsy for cancer. Analysis of cfDNA allows for… Read article →